Mark A Feitelson
Dr. Mark A. Feitelson attended Cypress College (Cypress, CA) from 1970-72, and then received a B.S. degree in biology from the University of California, Irvine in 1974. Advanced studies resulted in a Ph.D. in Microbiology and Immunology from the UCLA School of Medicine in 1979. He was then an American Cancer Society postdoctoral fellow in the Department of Medicine at Stanford University from 1980-1982, where he started his work with hepatitis B virus (HBV). Dr. Feitelson was then recruited to the Fox Chase Cancer Center by Dr. Baruch Blumberg (who won the Nobel Prize for his discovery of HBV) where he continued his work in HBV. In 1988, Dr. Feitelson became an independent faculty member at the Fox Chase Cancer Center at the rank of Associate Member. In 1991, Dr. Feitelson was recruited as an Associate Professor in the Department of Pathology, Anatomy and Cell Biology at Thomas Jefferson University, and from 1997-2007 has been a full-professor in the same department. He also held a secondary appointment in the Department of Microbiology and Immunology within the Kimmel Cancer Center at Jefferson. During this time, Dr. Feitelson ran a CAP certified clinical molecular diagnostic lab in microbiology for Thomas Jefferson University Hospital. Dr. Feitelson is presently Professor of Biology at Temple University and Associate Director of the Temple Biotechnology Center. Dr. Feitelson has over 100 publications in highly ranked international scientific journals, has written two books; delivered more than 160 oral presentations and/or posters at national and international scientific meetings, and has delivered more than 100 invited lectureships all over the world. Dr. Feitelson has recently been named outstanding alumnus of Cypress College.
Pathogenesis, Hepatitis B/C, Hepatocellular carcinoma.